Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107819 · ClinicalTrials.gov registry record
Metabolomics for Biomarker Discovery in Children With EoE
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 24
- Enrollment target
NCT03107819 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 24 participants.
The verdict
NCT03107819 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The investigators are seeking to enroll 8 children ages 2-18 already undergoing upper endoscopy. For the purposes of research, a peripheral blood and clean catch urine specimen will be obtained to measure plasma and urine metabolomics. The data will be used to determine if there are any key differences in the metabolite profile of subjects found to have eosinophilic esophagitis (EoE) versus non-EoE subjects. Once these metabolites are identified, the investigators will seek to enroll many more subjects for a validation phase.
Interventions
- DIAGNOSTIC_TEST Plasma and urine metabolomics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2018-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03107819
The ClinicalTrials.gov registry entry for NCT03107819 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Plasma and urine metabolomics is the first listed.
NCT03107819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03107819 about?
NCT03107819 is a clinical study titled "Metabolomics for Biomarker Discovery in Children With EoE". The investigators are seeking to enroll 8 children ages 2-18 already undergoing upper endoscopy. For the purposes of research, a peripheral blood and clean catch urine specimen will be obtained to measure plasma and urine metabolomics. The data will be used to determine if there are any key differen...
What is the current status of trial NCT03107819?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2017-03-29. Estimated completion is 2018-03-31.
What interventions are being tested in trial NCT03107819?
The interventions under investigation include: Plasma and urine metabolomics (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03107819?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.